Contact Us
Drug Search Results
More Filters [+]

Calcipotriol

Alternative Names: calcipotriol, calcipotriene, dovonex, daivonex, p-3073, p3073, p 3073, Enstilar, taclonex, dovobet, cal/bdp, mc2-01, mc2 01, sorilux, calcitrene, wynzora
Latest Update: 2024-12-17
Latest Update Note: Clinical Trial Update

Product Description

Calcipotriene (calcipotriol) is a synthetic drug derived from calcitriol otherwise known as vitamin D. It works by regulating the production and growth of skin cells.

Mechanisms of Action: VDR Agonist,STAT Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Psoriasis | Psoriasis | Psoriasis | Psoriasis

Known Adverse Events: Erythema | Folliculitis | Hypopigmentation | Urticaria | Psoriasis | Hypercalcemia | Headache

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Calcipotriol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

11/15/2024

News Article

 Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

09/27/2024

News Article

 LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China

05/20/2024

News Article

 Studies Show Linked Biological Pathways Driving Skin Inflammation

05/07/2024

News Article

 LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions